Study of the immunogenicity of 13-valent pneumococcal conjugate vaccine in high-risk patients who were outside recommended ages for routine vaccination
Latest Information Update: 14 Jun 2022
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Biomarker; Pharmacodynamics
Most Recent Events
- 08 Jun 2022 Status changed from active, no longer recruiting to completed.
- 09 Dec 2021 Status changed from recruiting to active, no longer recruiting.
- 28 Jan 2020 Status changed from not yet recruiting to recruiting.